Asteroid Menthol, Petrolatum, Zinc Oxide .098 g/28g; 22.302 g/28g; 1.4 g/28g Ointment — NDC 84107-552-02 (Billing 84107-0552-02)
This is a package of Asteroid Menthol, Petrolatum, Zinc Oxide .098 g/28g; 22.302 g/28g; 1.4 g/28g Ointment from HEALTHTEX LIMITED, marketed since Jul 2025 and currently FDA-listed. It is this product's only package size.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 2720028
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
Asteroid Menthol is a topical ointment sold over the counter under FDA monograph rules for skin care products. It contains menthol, which is typically used to produce a cooling sensation and mild numbing effect on the skin, along with petrolatum and zinc oxide, which function as moisturizers and skin protectants. This combination is commonly used to soothe minor skin irritation and help protect the skin barrier.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 84107-0552-02 You're viewing this Main listing | 1 TUBE in 1 CARTON / 28 g in 1 TUBE | 2025-07-22 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Asteroid .098 g/28g; 22.302 g/28g; 1.4 g/28gthis 84107-0552-02 | HEALTHTEX | 1 tube | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 512OYT1CRR
Cocoa butter is a natural fat extracted from cocoa beans. It's used in medicines as a base for suppositories and as a lubricant to help pills dissolve smoothly.
1 inactive ingredient listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses helps relieve burning, soreness, and itching by providing rapid acting cooling barrier ointment for external hemorrhoids and minor anal irritation.
⏱️ Dosage and Administration ▾
Directions Adults: Apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement.
⚠️ Warnings ▾
Warnings For external use only. Do Not Use Do not use if you are bleeding from the anal region. When using this product Do not exceed the recommended daily dosage unless directed by the doctor.
Do not put into rectum by using fingers or any mechanical device or applicator. Possible side effects may include a brief cooling or heating sensation on application. Stop use and ask a doctor if If allergic to the ointment or any of it's ingredients Bleeding occurs in the anal region Condition worsens or does not improve within 7 days.
If pregnant or breast-feeding Do not use if pregnant or breastfeeding. Keep out of reach of children If swallowed, get medical help, or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active Ingredients Menthol 0.35% Petrolatum 79.65% Zinc Oxide 5.00%
🧪 Inactive Ingredients ▾
Inactive ingredients Cocoa Butter, Petrolatum.
🎯 Purpose ▾
Purposes Anesthetic/Antipruritic/Analgesic Protectant Astringent
📄 Do Not Use ▾
Do Not Use Do not use if you are bleeding from the anal region.
📄 When Using This Product ▾
When using this product Do not exceed the recommended daily dosage unless directed by the doctor. Do not put into rectum by using fingers or any mechanical device or applicator. Possible side effects may include a brief cooling or heating sensation on application.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if If allergic to the ointment or any of it's ingredients Bleeding occurs in the anal region Condition worsens or does not improve within 7 days.
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding Do not use if pregnant or breastfeeding.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children If swallowed, get medical help, or contact a Poison Control Center right away.
📄 Other Information ▾
Other information Store at room temperature 68°-77°F (20°-25°C)
📄 Questions or Comments ▾
Questions? 1-800-819-9676 or visit neoqura.com
📄 Package Label / Principal Display Panel ▾
Principal Display Panel – 28 g Carton Label NDC 84107-552-02 neoqura asteroid™ ointment Hemorrhoid formulation Rapid acting cooling barrier ointment for burning soreness and itching associated with external hemorrhoids and minor anal irritation. + COOLS + SOOTHES + PROTECTS 1 TUBE | NET WT
1.0 OZ (28 g) Figure
Principal Display Panel – 28 g Tube Label neoqura asteroid™ ointment Hemorrhoid formulation Rapid acting cooling barrier ointment for burning soreness and itching associated with external hemorrhoids and minor anal irritation. + COOLS + SOOTHES + PROTECTS 1 TUBE NET WT
1.0 OZ (28 g) Figure
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |